The page is the record's research on the issuer — no analyst, no rating, no view. # Ascendis Pharma A/S (NASDAQ: ASND) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Ascendis Pharma A/S, listed on NASDAQ under ticker ASND. Its ISIN is not on the record and its LEI is not on the record. Its security type is Non-operating entity type (other). Its segment is not on the record. Its sector is 2834 Pharmaceutical Preparations and its jurisdiction is Denmark. Its listing status is listed, not halted. ## The disclosure read The record holds 117 filings in the twelve months from 2025-11-08 to 2026-11-08, across 68 filing days. Of these, 25 are directors' dealings, 42 are regulatory filings and 50 are results. The median gap between filing days is 3 days. The latest filing is dated 2026-11-06, is of type results, and is 2 days before the record date of 2026-11-08. NASDAQ has 4359 issuers with a median cadence gap of 6.0 days, a median of 52 filings and a median latency of 5.0 days. The sector 2834 Pharmaceutical Preparations has 526 issuers with a median cadence gap of 6.0 days, a median of 63.0 filings and a median latency of 4.0 days. ## Auditor The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds one listing, dated 2026-04-20. It holds no delisting and no name change. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record. The issuer is listed and not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes are on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 6 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://data.sec.gov/submissions/CIK0001612042.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ASND (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ASND (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ASND · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp